Human melioidosis reported by ProMED  by Nasner-Posso, Katherinn Melissa et al.
International Journal of Infectious Diseases 35 (2015) 103–106Human melioidosis reported by ProMED
Katherinn Melissa Nasner-Posso a,1, Stefania Cruz-Caldero´n a,1,
Franco E. Montu´far-Andrade b, David A.B. Dance c,d, Alfonso J. Rodriguez-Morales a,e,f,*
a Public Health and Infection Research Group and Incubator, Faculty of Health Sciences, Universidad Tecnolo´gica de Pereira, Pereira, Risaralda, Colombia
b Infectious Disease Section, Department of Internal Medicine, Hospital Pablo Tobo´n Uribe, Medellı´n, Antioquia, Colombia
c Lao–Oxford–Mahosot Hospital Wellcome Trust Research Unit, Vientiane, Lao People’s Democratic Republic
dCentre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
eWorking Group on Zoonoses, International Society for Chemotherapy, Aberdeen, UK
fCommittee on Zoonoses and Haemorrhagic Fevers, Asociacio´n Colombiana de Infectologı´a, Bogota´, DC, Colombia
A R T I C L E I N F O
Article history:
Received 10 February 2015
Received in revised form 2 May 2015
Accepted 5 May 2015
Keywords:
Melioidosis
ProMED
Epidemiology
S U M M A R Y
Objective: There are limited sources describing the global burden of emerging diseases. A review of
human melioidosis reported by ProMED was performed and the reliability of the data retrieved assessed
in comparison to published reports. The effectiveness of ProMED was evaluated as a source of
epidemiological data by focusing on melioidosis.
Methods: Using the keyword ‘melioidosis’ in the ProMED search engine, all of the information from the
reports and collected data was reviewed using a structured form, including the year, country, gender,
occupation, number of infected individuals, and number of fatal cases.
Results: One hundred and twenty-four entries reported between January 1995 and October 2014 were
identiﬁed. A total of 4630 cases were reported, with death reported in 505 cases, suggesting a
misleadingly low overall case fatality rate (CFR) of 11%. Of 20 cases for which the gender was reported, 12
(60%) were male. Most of the cases were reported from Australia, Thailand, Singapore, Vietnam, and
Malaysia, with sporadic reports from other countries.
Conclusions: Internet-based reporting systems such as ProMED are useful to gather information and
synthesize knowledge on emerging infections. Although certain areas need to be improved, ProMED
provided good information about melioidosis.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Melioidosis is a potentially fatal tropical disease caused by a
Gram-negative bacillus called Burkholderia pseudomallei.1–3 This
disease is acquired by inhalation, inoculation, or ingestion of
microorganisms normally present in water and moist soil,4 and
more rarely from other infected individuals (e.g., mothers with
mastitis).1 Melioidosis is known to be endemic in Southeast Asia
and Northern Australia, particularly between latitudes 208 N and
208 S, however sporadic cases have been reported in the Caribbean,
Central America, and South America.5,6 The incidence increases at
times of heavy rains, and the population groups at greatest risk are* Corresponding author.
E-mail address: arodriguezm@utp.edu.co (A.J. Rodriguez-Morales).
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(http://creativecommons.org/licenses/by/4.0/).farmers and indigenous inhabitants of rural tropical areas.4,7 The
disease usually has an incubation period of 1 to 21 days, although
long periods of latency may occur, and has a mortality rate
approaching 40% in developing countries.8,9 It causes a wide
spectrum of clinical manifestations10 that includes asymptomatic
seroconversion, pneumonia, atypical forms with neurological
involvement, and severe forms causing septicaemia and death.8,11
Alcohol consumption, diabetes mellitus, and chronic kidney
disease are risk factors for more severe disease.1,11 B. pseudomallei
infection requires prolonged antibiotic therapy to achieve the
eradication of the organism and prevent relapses.12
The global burden of melioidosis needs to be determined, but
there are limited sources from which to retrieve data regarding the
disease, which is not statutorily notiﬁable in most countries.
ProMED (The Program for Monitoring Emerging Diseases) is an
internet-based reporting system for emerging infectious or toxin-
mediated diseases.13–15 It was founded in 1994 and is currently a
program of the International Society for Infectious Diseases.13–16ciety for Infectious Diseases. This is an open access article under the CC BY license
Table 1
The number of infected and fatal melioidosis cases reported to ProMED between
1995 and 2014
Country Infected patients, n Reported deaths, n CFR (%)
Australia 1664 217 13
Thailand 1314 0 0
Singapore 941 227 24
Vietnam 343 0 0
Malaysia 221 34 15
Taiwan 77 12 16
UKa 14 0 0
India 12 0 0
Brazil 10 8 80
Finlanda 6 0 0
Papua New Guinea 6 3 50
Myanmar 6 0 0
Bangladesh 5 0 0
Belgiuma 2 0 0
Spaina 2 0 0
USAa 2 1 50
Madagascar 2 2 100
Israela 1 0 0
Mauritius 1 1 100
Sri Lanka 1 0 0
Total 4630 505 11
CFR, case fatality rate.
a Imported cases.
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tion of information that may lead to early preventive measures,
prevent the spread of outbreaks, and provide more accurate
disease control. Its sources of information include media reports,
ofﬁcial reports, online summaries, reports from local observers,
and others.16 The reports are reviewed and edited by expert
moderators in the ﬁeld of infectious diseases and are then
submitted to the mail server and published on the website and
disseminated to subscribers by e-mail. Being a non-proﬁt,
non-governmental system, it is free from governmental con-
straints.13–16 It currently has over 70 000 subscribers in over
185 countries.16
In this study, the human melioidosis incidents reported by
ProMED were reviewed and the reliability of the data retrieved
assessed in comparison to published reports. The effectiveness of
ProMED as an epidemiological data source was thus evaluated by
focusing on melioidosis.
2. Methods
The keyword ‘melioidosis’ was used in the ProMED search
engine, looking at ProMED-mail (English), ProMED-ESP (Spanish),
ProMED-FRA (French), and ProMED-PORT (Portuguese). All the
information in the individual reports was reviewed and the data
collected using a structured form, including year, country, gender,
occupation, the number of infected individuals, and the number of
fatal cases.
3. Results
One hundred and twenty-four entries reported between
January 1995 and October 2014 were identiﬁed (119 from
ProMED-mail, four from ProMED-ESP, and one from ProMED-
PORT). A total of 4630 cases were reported, with 505 cases
recorded as being fatal, giving a reported case fatality rate (CFR) of
11%. Gender was only recorded in 20 cases, with 12 (60%) of these
being male. Of 17 cases for which the age was reported, the median
aged was 45 years (range 17–80 years). The occupational status
was only reported for six, of whom three were farmers, one was a
gardener, one was a housewife, and one was a student. Twenty-ﬁve
cases were reported as imported. Countries of origin were India
(n = 9; all to the UK), Thailand (n = 5; three cases to Finland, one to
Belgium, and one to Israel), Bangladesh (n = 3; all to the UK),
Honduras (n = 2; both to the USA), Gambia (n = 1; to Spain), and
Madagascar (n = 1; to Belgium); two cases had travelled to Finland
and Spain from unspeciﬁed countries in Asia and Africa,
respectively.
The distribution of the infected and fatal cases by country is
presented in Table 1. Most of the cases were reported from
Australia, followed by Thailand, Singapore, Vietnam, and Malaysia.
The lowest fatality rates were reported from Australia (13%) and
Malaysia (15%). Amongst cases from Australia, 1381 (83%) were
from the Northern Territory (with at least 1059 from Darwin
(77%)).
4. Discussion
It is well known that B. pseudomallei infection is endemic in
Southeast Asia and Northern Australia, but as sporadic cases have
been reported with a wide geographical distribution, systems such
as ProMED provide an opportunity to alert the international
community to the occurrence of cases around the world, including
the identiﬁcation of new foci of endemicity. In addition, the
occurrence of clusters of cases in an atypical location might alert
public health authorities to the possibility of the deliberate release
of B. pseudomallei, a tier 1 biothreat agent.17 When compared withthe information provided by reports in the subject literature, the
most notable ﬁnding was that the CFR identiﬁable from ProMED
was low in comparison with the published literature from the
developing world;6,8,18,19 however, under-reporting of fatal cases
by ProMED is not surprising, as the purpose is to act as an early
alert system, and outcomes may not be known at the time of
posting. In addition, the data were very incomplete with regards to
characteristics such as gender, age, and occupation.
In the present study, the highest numbers of reported cases of
melioidosis on ProMED were from Australia (1664 cases) and
Thailand (1314), which is consistent with the known epidemiology
of the disease, although the total number of cases diagnosed each
year in Thailand is higher than that in Northern Australia due to the
greater numbers of exposed individuals.5,6,18–21 Countries like
Singapore and Malaysia are also known to be endemic for
melioidosis,5 whilst Taiwan, Brazil, and Papua New Guinea have
also reported sporadic cases of melioidosis, sometimes related to
speciﬁc climate events,7,22–24 which is also consistent with the
results found in ProMED.
Within Australia, melioidosis is most frequently reported from
north Queensland and the ‘Top End’ of the Northern Territory. One
hundred and seventy-six cases conﬁrmed by culture were reported
from northern Queensland during the period from 2000 to 2009,
with an overall CFR of 21%, falling to 14% in the years between
2005 and 2009.25,26 A similar CFR (19%) was reported from the
Northern Territory during the years 1990–2000,26,27 comparable to
the 13% mortality amongst cases reported on ProMED (Table 1).
The greater representation of reports from the Northern Territory
of Australia on ProMED is likely to be skewed, reﬂecting the fact
that the public health authorities in the Northern Territory have a
proactive annual publicity campaign to alert people to the risk of
melioidosis at the start of the rainy season, which is then picked up
by ProMED.
In Singapore, the mortality rate decreased from a CFR of 60% in
1989 to 27% in 1996,28 with 693 cases of melioidosis and
112 deaths reported between 1998 and 2007, equivalent to a
CFR of 16.2%,29which is also close to that found from ProMED (24%)
(Table 1). Between 2003 and 2012, 550 cases were reported in
Singapore, with rainfall and humidity levels being found to be
associated with disease incidence during that period.20
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and Australia is likely to be related to increased awareness
amongst medical staff, allowing earlier diagnosis and treatment of
early-stage disease,28 optimal antibiotic therapy, and improved
supportive management. On the other hand, a prospective cohort
study in the northeast of Thailand identiﬁed 2243 patients
between 1997 and 2006, with a CFR of 42.6% (the third leading
cause of death from infectious diseases after HIV and tuberculo-
sis),20 a rate that is much higher than the data from ProMED would
suggest (Table 1).
By contrast, although ProMED captured information about
some countries in which melioidosis is rarely reported, such as
Madagascar, Mauritius, and Brazil, the high CFRs (100%, 100%, and
80% respectively; Table 1) amongst cases from these countries
reported on ProMED are likely to be due to the low denominators,
with reporting skewed to the recognition of more severe cases,
compounded by a lack of awareness amongst medical staff leading
to sub-optimal case management. Clearly ProMED cannot always
be regarded as an accurate source of information about patient
outcome, which is not surprising as that is not its purpose.
For Vietnam, the 343 cases included in Table 1 corresponded to
historic information reported to ProMED-mail from GIDEON
(http://www.gideononline.com/), a system that captures and
collates information about infectious diseases from a wide range
of sources including the published literature, and related to cases
that were reported (as of 1973) among American Troops during the
Vietnam War. The disease is probably still prevalent in Vietnam,
although it is relatively rarely diagnosed among the indigenous
population.
While this search on ProMED identiﬁed no cases reported from
Colombia, indigenous melioidosis has recently been recognized
there, with 10 cases originating from different parts of the country
recently reported in the Spanish literature.30,31 Indeed, Brazil is the
only country in the Americas amongst the ProMED reports, despite
the fact that sporadic cases have also been reported from other
countries in the region, such as Costa Rica and Puerto Rico.9,32,33 It
is likely that the low reported incidence of melioidosis in countries
of the Americas is associated with a lack of awareness amongst
clinical and laboratory staff, leading to a failure to identify the
microorganism, thereby underestimating the true incidence of
infection.20,29 It is important to ensure that the identiﬁcation of
melioidosis in a new area is widely communicated to healthcare
staff in order for appropriate methods to be used to conﬁrm the
diagnosis by sampling, laboratory culture, isolation, and identiﬁ-
cation of B. pseudomallei whenever possible.8 Furthermore, it is
notable that more than 95% of ProMED reports were in English
and less than 5% in other languages, including Spanish, meaning
that those who only subscribe in languages other than English
would not have received signiﬁcant information about melioi-
dosis. This has probably been inﬂuenced by the fact that there is
not yet enough awareness of melioidosis in Francophone and
Hispanophone countries in Latin American, the Caribbean, and
Africa.
Although ProMED proved to be a useful source of information
about melioidosis, it was evident that it gave a misleading
impression of the distribution and mortality in some areas, as has
been reported previously for other infections.13 We think it would
be useful to consider the adoption of standardized templates for
reporting to ProMED in order to enhance the standardization of
data and provide clear, accurate, and reliable information that
could be used to conduct epidemiological analyses in order to
establish the status of emerging diseases and assist in their
recognition and control. In addition, we think it would be useful for
reports in one language to be mirrored to ProMED in other
languages, especially when it is the language of the country from
which the report originated.In addition, ProMED may be useful as a source of information for
travel medicine practice.10 Melioidosis is well described amongst
both short- and long-term visitors to endemic areas and so needs to
be considered in the evaluation and treatment of patients with
sepsis or other febrile illnesses returning from endemic coun-
tries,34,35 particularly from Southeast Asia and Northern Australia as
has been seen in this study. Melioidosis should be considered in
anyone with compatible clinical manifestations, even in the absence
of apparent risk of exposure to B. pseudomallei. A greater
appreciation of this disease among physicians in non-endemic
areas should lead to better management of imported cases, and
ProMED could also be a source of epidemiological information when
giving pre-travel advice and conducting post-travel consultations.
In regions, such as South America, where reports of melioidosis
have emerged relatively recently, strategies for surveillance and
recognition of melioidosis need to be strengthened. Working groups
of national infectious diseases societies could help to increase the
awareness among general and infectious diseases practitioners, but
might also inﬂuence public health authorities by suggesting that
melioidosis becomes a notiﬁable disease in each country.
In conclusion, information systems such as ProMED provide
insight through daily reports of the occurrence of both individual
cases and clusters of infectious diseases. This helps the rapid
dissemination of knowledge of the current global situation of
emerging infectious diseases and their outcomes in terms of
morbidity, disability, and death. However, the data on ProMED are
often incomplete and it is important to continue improving and
supplementing these systems to allow a more precise knowledge
of the worldwide epidemiology of emerging diseases such as
melioidosis.
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